These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 21872376)

  • 1. Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.
    Lewis EJ; Lewis JB; Greene T; Hunsicker LG; Berl T; Pohl MA; de Zeeuw D; Heerspink HL; Rohde RD; Atkins RC; Reutens AT; Packham DK; Raz I;
    Am J Kidney Dis; 2011 Nov; 58(5):729-36. PubMed ID: 21872376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
    Heerspink HL; Greene T; Lewis JB; Raz I; Rohde RD; Hunsicker LG; Schwartz SL; Aronoff S; Katz MA; Eisner GM; Mersey JH; Wiegmann TB;
    Nephrol Dial Transplant; 2008 Jun; 23(6):1946-54. PubMed ID: 18089623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
    Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J;
    Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.
    Gambaro G; Kinalska I; Oksa A; Pont'uch P; Hertlová M; Olsovsky J; Manitius J; Fedele D; Czekalski S; Perusicová J; Skrha J; Taton J; Grzeszczak W; Crepaldi G
    J Am Soc Nephrol; 2002 Jun; 13(6):1615-25. PubMed ID: 12039991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
    Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
    Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
    Marre M; Lievre M; Chatellier G; Mann JF; Passa P; Ménard J;
    BMJ; 2004 Feb; 328(7438):495. PubMed ID: 14960504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year course of oral sulodexide in the management of diabetic nephropathy.
    Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
    J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.
    Packham DK; Wolfe R; Reutens AT; Berl T; Heerspink HL; Rohde R; Ivory S; Lewis J; Raz I; Wiegmann TB; Chan JC; de Zeeuw D; Lewis EJ; Atkins RC;
    J Am Soc Nephrol; 2012 Jan; 23(1):123-30. PubMed ID: 22034636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulodexide for diabetic nephropathy: another one bites the dust.
    House AA; Weir MA
    Am J Kidney Dis; 2011 Nov; 58(5):692-4. PubMed ID: 22014634
    [No Abstract]   [Full Text] [Related]  

  • 10. Discounting the efficacy of sulodexide in diabetic nephropathy is premature.
    Gambaro G
    Am J Kidney Dis; 2012 Jul; 60(1):169-70. PubMed ID: 22709598
    [No Abstract]   [Full Text] [Related]  

  • 11. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Jin SM; Han KA; Yu JM; Sohn TS; Choi SH; Chung CH; Park IeB; Rhee EJ; Baik SH; Park TS; Lee IK; Ko SH; Hwang YC; Cha BS; Lee HW; Nam MS; Lee MK
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2108-14. PubMed ID: 27493100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
    Zalevskaia AG; Astamirova KhS; Karpova IA; Popova SG
    Ter Arkh; 1998; 70(3):71-4. PubMed ID: 9575594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review.
    Li R; Xing J; Mu X; Wang H; Zhang L; Zhao Y; Zhang Y
    Drug Des Devel Ther; 2015; 9():6275-83. PubMed ID: 26664049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial.
    Fallahzadeh MK; Dormanesh B; Sagheb MM; Roozbeh J; Vessal G; Pakfetrat M; Daneshbod Y; Kamali-Sarvestani E; Lankarani KB
    Am J Kidney Dis; 2012 Dec; 60(6):896-903. PubMed ID: 22770926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
    Skrha J; Perusicová J; Pont'uch P; Oksa A
    Diabetes Res Clin Pract; 1997 Oct; 38(1):25-31. PubMed ID: 9347243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
    Ito S; Shikata K; Nangaku M; Okuda Y; Sawanobori T
    Clin J Am Soc Nephrol; 2019 Aug; 14(8):1161-1172. PubMed ID: 31248950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Game not over for sulodexide.
    Coccheri S
    Am J Kidney Dis; 2012 Mar; 59(3):467. PubMed ID: 22340910
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy.
    Blouza S; Dakhli S; Abid H; Aissaoui M; Ardhaoui I; Ben Abdallah N; Ben Brahim S; Ben Ghorbel I; Ben Salem N; Beji S; Chamakhi S; Derbel A; Derouiche F; Djait F; Doghri T; Fourti Y; Gharbi F; Jellouli K; Jellazi N; Kamoun K; Khedher A; Letaief A; Limam R; Mekaouer A; Miledi R; Nagati K; Naouar M; Sellem S; Tarzi H; Turki S; Zidi B; Achour A;
    J Nephrol; 2010; 23(4):415-24. PubMed ID: 20175052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.